Soluble plasma HLA peptidome as a potential source for cancer biomarkers - Wikidata - awgldk - TriplyDB

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

http://www.wikidata.org/entity/Q34279102

about

Radiotherapy combination opportunities leveraging immunity for the next oncology practice Whole Tumor Antigen Vaccines: Where Are We?DRiPs solidify: progress in understanding endogenous MHC class I antigen processing Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond.Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis Application of proteomics to cancer early detection Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology Overexpression of G6PD and HSP90 Beta in Mice with Benzene Exposure Revealed by Serum Peptidome Analysis Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion.Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.Rationalising the role of Keratin 9 as a biomarker for Alzheimer's disease.Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity.Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.The nature and extent of contributions by defective ribosome products to the HLA peptidome.The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.Tools to define the melanoma-associated immunopeptidome.Deciphering the MHC-associated peptidome: a review of naturally processed ligand data.High-resolution analysis of the murine MHC class II immunopeptidome.Current tools for predicting cancer-specific T cell immunity.Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigens.High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome.Characterization of the Low-Molecular-Weight Human Plasma Peptidome.The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery.The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction.Multiplexed Temporal Quantification of the Exercise-regulated Plasma Peptidome.Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.A tissue-based draft map of the murine MHC class I immunopeptidome Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry Immunocytokines

P2860

Q26738443-0ADE630A-0A10-4138-8295-72B89485D599 Q26783866-87708DF8-32B0-4117-B30C-51D679DC4E4B Q27006750-0635323F-F14D-401A-80CA-8B5F562196A8 Q28066935-95982D5A-43EE-4904-94FB-6FA30B273641 Q28743282-8FC2FAC5-41B0-4984-A89B-37DA8E759A69 Q30002365-AFEE19D0-FE6F-4C0E-A501-F329F928E165 Q33606161-2BEA5E71-5E29-4E24-A176-006C282E5A69 Q33897503-DAC72EF2-467D-4DDD-AD36-188D4221F4BD Q34279125-F95835FD-3E9E-4CC2-A752-9F82504EEDDC Q34616781-5CEDE0EF-C2B8-4627-B201-37702B0CEF26 Q35053031-1233C325-7D59-4E6D-8CAF-7B9F30583E8A Q35461138-298DE591-0486-490D-AEE9-77763834635A Q35778234-9D795C4D-7010-436C-AB21-FD6E799E2A61 Q36539516-105686AF-2405-49BD-91B2-5705BC432305 Q36604367-E668A4A1-B2AE-4C50-BB52-9AB9FB5B306D Q36681693-040A1705-168F-4949-8619-742C3F8C18C8 Q36905613-208BE284-80D9-4254-AD31-1C3AAB1623B1 Q37185752-52424C67-45C1-4CDB-8DAA-DCDC2C967D5F Q37644973-29A6B20E-CC4E-415F-B9A3-9A4EAF500220 Q37725183-7EE353F8-DF45-452E-B69A-665B5B9FE964 Q38380973-E8918530-B78D-4BE6-BECB-E4A97AC5FC02 Q38650013-C56F40E7-5578-4F40-9675-927B0310BDC6 Q38653176-1BCC7731-D7A2-47F7-930C-88610B45393C Q38825612-CA59122E-0598-4AEF-B968-1ACF6C91D180 Q38953021-9B1241FB-7E48-47A2-B23F-F8ED75458E3E Q39003786-1515C2A0-5D01-4675-AB31-2A8E95045534 Q41279621-3F3A2E93-493C-4783-910E-D40F4A80F80E Q41410124-A232C241-287E-43B9-86D2-D6D46C92A5BB Q41514095-EC8C98C7-17F3-4C1A-8184-75B75DB3EDAA Q43097138-470C2594-94EF-4730-9FBA-C4CB26F9B6B1 Q46340998-03C3207C-E521-458E-942E-AD4B85C517E3 Q46485465-54B20CB5-E0B5-4B90-8D5D-08FE62D90602 Q47158142-E8C5B4D4-BBA5-416A-8636-AEECDE4A9D2D Q47190955-92A3A3B2-9B66-4318-B8DD-2F4D82C678B6 Q47690619-223B3DE4-9EEF-4988-9D7B-B6C8E19C9C11 Q49586408-C050B74F-F21A-494D-8099-1208E553213F Q49836890-99D1FDCA-E8A7-490A-B0B1-E7713FAA08C0 Q57170495-72B9FA9F-9D4B-441C-8C6E-5F0026E5D01A Q57178228-5D7B0613-4405-4B7E-865A-66A078B0C09D Q57911975-3D4FCDC5-EAC7-4343-9DC4-1602CC1B2DE1

P2860

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

http://www.wikidata.org/entity/Q34279102

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@ast

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@en

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@nl

type

label

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@ast

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@en

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@nl

prefLabel

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@ast

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@en

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@nl

P1433

Q34279102-E5FE04B6-CEBF-4E6A-8C63-9187879AB1D6

P1476

Q34279102-379AFCD0-F14B-45F3-9855-15AC3B264D5C

P2093

Q34279102-0E9F9922-29D5-4540-8290-E8483E95A105

Q34279102-2657597A-FE65-4AAC-AF28-249CA562B5AE

Q34279102-388B9DDB-BA6A-4854-AE84-93E09D5E3B50

Q34279102-75BBCD3C-442D-4B08-BB86-AE1697E6E994

Q34279102-B2C931EE-59A5-4355-9C76-31F78C36792C

Q34279102-C5E932F6-64B5-4A98-9736-9E1382365FBD

P2860

Q34279102-103A683B-09CE-4FBA-8885-D70E77F91647

Q34279102-1B1A4D59-7EC1-4B15-89BD-2F2ED5F4E198

Q34279102-1B7970CD-C5AD-4517-8E3E-7230E8DE5C03

Q34279102-1B7FA82C-8B41-4B21-BA3F-C66D5DDD8D1F

Q34279102-1CADEBA7-6A92-4B07-B757-B315F1818023

Q34279102-1EA37ED2-74AC-436C-8DBC-485B809AB9CB

Q34279102-22D82B87-63D2-4E45-92BC-E72C55107E99

Q34279102-23CF1CF5-890C-4C95-9A35-338A73FE3ACA

Q34279102-2B3CA1AC-8EC9-44D9-AB28-FFE344EABCA4

Q34279102-2B542D9B-746D-4A41-9407-09A2D172367F

P304

Q34279102-9831AA3A-EA8F-49BC-A949-E764BC23E51C

P31

Q34279102-9AE6132F-83DC-40D0-ADC0-D36E00D4818E

P356

Q34279102-A86F4986-226C-4164-A1AD-67830C4A88EC

P407

Q34279102-6166ED70-AD5E-4926-A119-B391DF37C70C

P433

Q34279102-45B31D64-F4C9-4C72-9A4A-8EE2789F72BE

P478

Q34279102-9FE7B65D-3162-4F51-84F2-1A4739E587B8

P577

Q34279102-6FD7F2E3-5FA9-4EC6-9FDB-B87C22F3CF7B

P5875

Q34279102-7381AC11-1480-41CD-A0AD-796F3C2EC45E

P698

Q34279102-EBE1B914-C401-4B70-A268-1EC441CD4F6B

P921

Q34279102-48B00096-A9C6-468B-AFF3-B66DD76AF710

P932

Q34279102-79D1A1C8-BE70-47E4-92C1-CE106988FE21

P356

PNAS.1008501107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

@en

P2093

Arie Admon

http://www.w3.org/2001/XMLSchema#string

Eilon Barnea

http://www.w3.org/2001/XMLSchema#string

Ilan Beer

http://www.w3.org/2001/XMLSchema#string

Irit Avivi

http://www.w3.org/2001/XMLSchema#string

Michal Bassani-Sternberg

http://www.w3.org/2001/XMLSchema#string

Tami Katz

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of albumin-associated peptides and proteins from ovarian cancer patients

Probability-based protein identification by searching sequence databases using mass spectrometry data

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

SYFPEITHI: database for MHC ligands and peptide motifs

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.

Improving large-scale proteomics by clustering of mass spectrometry data.

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.

Differential exoprotease activities confer tumor-specific serum peptidome patterns

Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.

HLA class I supertypes: a revised and updated classification.

P304

18769-18776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1008501107

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47544362

http://www.w3.org/2001/XMLSchema#string

P698

20974924

http://www.w3.org/2001/XMLSchema#string

P921

P932

2973870

http://www.w3.org/2001/XMLSchema#string